What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Ischemia, Stroke, Internal medicine, Neuroprotection and Cerebral blood flow are his primary areas of study.
His Ischemia research includes themes of Immunology, Pharmacology, In vivo and Pathology.
His study in Stroke is interdisciplinary in nature, drawing from both Clinical trial, Intensive care medicine, Excitotoxicity, Physical therapy and Neuroscience.
His research in Internal medicine intersects with topics in Endocrinology, Surgery and Cardiology.
His Neuroprotection research includes elements of Glutamate receptor, Receptor, Apoptosis, Cell biology and Ischemic preconditioning.
His study on Cerebral blood flow is covered under Anesthesia.
His most cited work include:
- Pathobiology of ischaemic stroke: an integrated view (3171 citations)
- Near infrared spectroscopy (NIRS) : a new tool to study hemodynamic changes during activation of brain function in human adults (902 citations)
- Ischemic tolerance and endogenous neuroprotection (717 citations)
What are the main themes of his work throughout his whole career to date?
Ulrich Dirnagl mostly deals with Internal medicine, Stroke, Ischemia, Cerebral blood flow and Neuroscience.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Cardiology.
His research investigates the connection between Stroke and topics such as Clinical trial that intersect with problems in Publication bias.
He interconnects Inflammation, Neuroprotection and Pathology in the investigation of issues within Ischemia.
The various areas that Ulrich Dirnagl examines in his Neuroprotection study include Excitotoxicity, Glutamate receptor and Ischemic preconditioning.
His Cerebral blood flow research is multidisciplinary, incorporating elements of Oxygenation, Hemodynamics and Laser Doppler velocimetry, Blood flow.
He most often published in these fields:
- Internal medicine (24.53%)
- Stroke (23.06%)
- Ischemia (19.92%)
What were the highlights of his more recent work (between 2014-2021)?
- Stroke (23.06%)
- Internal medicine (24.53%)
- Clinical trial (5.87%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Stroke, Internal medicine, Clinical trial, Immunology and Quality.
His studies in Stroke integrate themes in fields like Lesion, Cancer, Randomized controlled trial, Magnetic resonance imaging and Ischemia.
The Brain ischemia research Ulrich Dirnagl does as part of his general Ischemia study is frequently linked to other disciplines of science, such as Phagoptosis, therefore creating a link between diverse domains of science.
Ulrich Dirnagl combines subjects such as Endocrinology, Spinal cord injury, Oncology and Cardiology with his study of Internal medicine.
As part of the same scientific family, Ulrich Dirnagl usually focuses on Clinical trial, concentrating on Anesthesia and intersecting with Natalizumab, Fingolimod, Excitotoxicity, Intensive care medicine and Thrombolysis.
Cerebral blood flow is closely attributed to Neuroscience in his research.
Between 2014 and 2021, his most popular works were:
- Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation (394 citations)
- Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation (394 citations)
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research (221 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
The scientist’s investigation covers issues in Stroke, Immunology, Internal medicine, Spinal cord injury and Transparency.
His Stroke research integrates issues from Lesion, Clinical trial, Magnetic resonance imaging, Natalizumab and Peritoneal dialysis.
His Clinical trial research is multidisciplinary, relying on both Thrombolysis, Neuroprotection, Intensive care medicine, Excitotoxicity and Fingolimod.
His study in the fields of Immune system, Epitope and Antibody under the domain of Immunology overlaps with other disciplines such as Tolerance induction.
As a part of the same scientific study, Ulrich Dirnagl usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Reflex.
His work in Brain ischemia tackles topics such as STAT protein which are related to areas like Ischemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
